Absence of acute rejection using basiliximab with triple immunosuppression in cadaveric kidney recipients in first three months

Transplant Proc. 2001 Nov-Dec;33(7-8):3207-8. doi: 10.1016/s0041-1345(01)02365-x.
No abstract available

MeSH terms

  • Acute Disease
  • Adult
  • Antibodies, Monoclonal / therapeutic use*
  • Basiliximab
  • Cyclosporine / blood
  • Cyclosporine / therapeutic use*
  • Drug Therapy, Combination
  • Female
  • Graft Rejection / prevention & control*
  • Histocompatibility Testing
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Kidney Transplantation / immunology*
  • Male
  • Middle Aged
  • Postoperative Complications / classification
  • Postoperative Complications / epidemiology
  • Recombinant Fusion Proteins*
  • Sex Characteristics
  • Time Factors

Substances

  • Antibodies, Monoclonal
  • Immunosuppressive Agents
  • Recombinant Fusion Proteins
  • Cyclosporine
  • Basiliximab